Astech appoints business development manager

Astech Projects has boosted its sales team with the appointment of John Roberts as business development manager.

Astech Projects has expanded its packaging robotics and consumer goods testing markets sales team with the appointment of John Roberts as business development manager.

Roberts has more than 15 years' experience in the packaging industry and the Runcorn supplier of automation products hopes to use this to establish the company as a world class systems integrator within these specialised markets.

You may also like

Hi Tech Manufacturing

CiP white paper: Photon based gravimetry for high throughput tablet weighing: A technical assessment

Author: Phillip Ruda. "This research was predicated on a late-night conversation between two friends. The kind of 'what-if' question which seems so bonkers you feel compelled to discover by what orders of magnitude it is completely off-the-wall in an attempt to discover a useful grain of truth somewhere in process. My apologies to the real scientists who very serious models we attempted to use to prove or disprove crazy theory. We thought it just about daft enough to share. Enjoy."
Regulatory

Shimadzu launches ALTRACE energy dispersive X-ray fluorescence spectrometer

High-sensitivity analysis and automated measurements for food, environmental, and pharmaceutical inspections
Packaging

Sharp Services invests $100m to expand global sterile and packaging capacity across US and Europe

The investment will boost sterile fill/finish, injectable packaging and oral solid dose capacity across Sharp's US and European sites, strengthening its clinical and commercial manufacturing network to meet growing pharmaceutical demand
Regulatory

Abzena advances immunogenicity risk assessment in biologic drug development

New white paper explores how early testing helps predict and prevent unwanted immune responses in therapeutic proteins
Regulatory

Immusoft receives FDA Fast Track Designation for ISP-001, a first-in-class engineered B cell therapy for MPS I

Immusoft’s ISP-001, designed to deliver continuous enzyme production through engineered B cells, becomes the first clinical-stage therapy of its kind to receive FDA Fast Track designation
Regulatory

MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results

The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares fall by about 90%, prompting an investigation into whether or not they were misled
Regulatory

NAD+ supplement claims under scrutiny as Niagen Bioscience wins landmark advertising case

The National Advertising Division (NAD) has ruled against Reus Research over unsupported NAD+ product claims, reinforcing that oral NAD+ ingestion lacks scientific backing and affirming Niagen’s clinically proven approach
Subscribe now